10x Genomics (NASDAQ:TXG – Get Free Report) had its price target reduced by investment analysts at Citigroup from $20.00 to $15.00 in a note issued to investors on Tuesday,Benzinga reports.

Includes reviews of Autoflex Leasing from DealerRater. Want to share your experience with this dealership? I want to thank Daniel and Autoflex for you patience and hard work to help me with my new ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Get Our Latest Analysis on TXG Torex Gold Resources Price Performance TSE:TXG opened at C$31.59 on Friday. The stock has a market cap of C$1.92 billion, a PE ratio of 16.98, a P/E/G ratio of 0.02 ...

MediaTek's latest chipsets continue the trend of marginal overhauls over their predecessors. The brand-new Dimensity 7400 and 7400X are near carbon copies of last year’s Dimensity 7300 and 7300X ...

Benjamin J. Hindson, the See Remarks of $TXG, sold 4,573 shares of the company on 02-24-2025 for an estimated $50,602. We received data on the trade from a recent SEC ...

ALAN MATEO, a director at $TXG, bought 40,000 shares of the company on 02-21-2025 for an estimated $445,572. This trade was reported by Quiver Quantitative using data ...

Fintel reports that on February 13, 2025, Leerink Partners downgraded their outlook for 10x Genomics (NasdaqGS:TXG) from Outperform to Market Perform. Analyst Price Forecast Suggests 71.13% Upside ...